Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene

By Lahiri Debomoy  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 225-233

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease

By Marques Marcos   Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 327-337

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer’s disease

By Frey C.   Bonert A.   Kratzsch T.   Rexroth G.   Rösch W.   Müller-Spahn F.   Maurer K.   Müller W. E.   Eckert A.  

Journal of Neural Transmission, Vol. 113, Iss. 11, 2006-11 ,pp. : 1753-1761

Springer Publishing Company

Access to resources Recommend Favorite

Tuberin – A New Molecular Target in Alzheimer’s Disease?

By Ferrando-Miguel Rosa   Rosner Margit   Freilinger Angelika   Lubec Gert   Hengstschläger Markus  

Neurochemical Research, Vol. 30, Iss. 11, 2005-11 ,pp. : 1413-1419

Springer Publishing Company

Access to resources Recommend Favorite

Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer’s disease

By Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 181-188

Humana Press, Inc

Access to resources Recommend Favorite